Showing results (431-440 of 574) with videos related to
Sort By:
Pageof 58
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2011
Host defense peptide LL-37 selectively reduces proinflammatory macrophage responsesKelly L Brown, Grace F T Poon, Darlene Birkenhead, et al.Journal of Innate Immunity|April 9, 2010
Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathwayJelena Pistolic, Celine Cosseau, Yuexin Li, et al.Plos Neglected Tropical Diseases|February 5, 2009
Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18Lee R Haines, Jamie M Thomas, Angela M Jackson, et al.Vaccine|May 21, 2013
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodiesMonika Polewicz, Aleksandra Gracia, Srinivas Garlapati, et al.Microbial Genomics|August 23, 2021
Genomic insights into the diversity, virulence and resistance of Klebsiella pneumoniae extensively drug resistant clinical isolatesAmy H Y Lee, William F Porto, Célio de Faria, et al.Journal of Bacteriology|June 12, 2012
Transcription of the oprF gene of Pseudomonas aeruginosa is dependent mainly on the SigX sigma factor and is sucrose inducedEmeline Bouffartigues, Gwendoline Gicquel, Alexis Bazire, et al.Plos One|January 26, 2013
The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein EDhananjay R Namjoshi, Georgina Martin, James Donkin, et al.Biointerphases|April 23, 2010
X-ray spectromicroscopy study of competitive adsorption of protein and peptide onto polystyrene-poly(methyl methacrylate)Bonnie O Leung, Adam P Hitchcock, John L Brash, et al.Journal of Chemical Information and Modeling|December 23, 2025
Design of Highly Potent Antibiofilm, Antimicrobial Peptides Using Explainable Artificial IntelligenceKarina Pikalyova, Tagir Akhmetshin, Alexey Orlov, et al.Vaccine|November 15, 2011
Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infectionTyler H T Brown, Jason David, Elizabeth Acosta-Ramirez, et al.Pageof 58